- Home
- RCUS vs PL Comparison
RCUS vs PL Comparison
Compare RCUS & PL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- PL
- Stock Information
- Founded
- RCUS 2015
- PL 2010
- Country
- RCUS United States
- PL United States
- Employees
- RCUS N/A
- PL N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- PL Aerospace
- Sector
- RCUS Health Care
- PL Industrials
- Exchange
- RCUS Nasdaq
- PL Nasdaq
- Market Cap
- RCUS 1.4B
- PL 1.3B
- IPO Year
- RCUS 2018
- PL N/A
- Fundamental
- Price
- RCUS $14.15
- PL $4.67
- Analyst Decision
- RCUS Buy
- PL Strong Buy
- Analyst Count
- RCUS 12
- PL 9
- Target Price
- RCUS $34.50
- PL $4.34
- AVG Volume (30 Days)
- RCUS 583.4K
- PL 4.3M
- Earning Date
- RCUS 02-19-2025
- PL 12-09-2024
- Dividend Yield
- RCUS N/A
- PL N/A
- EPS Growth
- RCUS N/A
- PL N/A
- EPS
- RCUS N/A
- PL N/A
- Revenue
- RCUS $263,000,000.00
- PL $241,650,000.00
- Revenue This Year
- RCUS $127.65
- PL $14.34
- Revenue Next Year
- RCUS N/A
- PL $12.08
- P/E Ratio
- RCUS N/A
- PL N/A
- Revenue Growth
- RCUS 119.17
- PL 12.49
- 52 Week Low
- RCUS $13.51
- PL $1.67
- 52 Week High
- RCUS $20.31
- PL $4.99
- Technical
- Relative Strength Index (RSI)
- RCUS 39.00
- PL 64.65
- Support Level
- RCUS $13.81
- PL $3.76
- Resistance Level
- RCUS $14.45
- PL $4.03
- Average True Range (ATR)
- RCUS 0.57
- PL 0.26
- MACD
- RCUS -0.06
- PL -0.01
- Stochastic Oscillator
- RCUS 30.40
- PL 92.98
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About PL Planet Labs PBC
Planet Labs PBC is an Earth-imaging company. The company provides daily satellite data that helps businesses, governments, researchers, and journalists understand the physical world and take action.